Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pharmacological reviews

Showing results (1-10 of 822) with videos related to

Pageof 83
Sort By:
Pharmacological Reviews|September 8, 2001
The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor familyJ S Mogil, G W Pasternak
Pharmacological Reviews|November 14, 2002
Pivalate-generating prodrugs and carnitine homeostasis in manEric P Brass
Pharmacological Reviews|November 14, 2002
Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart diseaseAngelika De Bree, W M Monique Verschuren, Daan Kromhout, et al.
Pharmacological Reviews|June 2, 2000
Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammationA W Griffioen, G Molema
Pharmacological Reviews|May 31, 2002
International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclatureAnthony P Davenport
Pharmacological Reviews|May 31, 2002
International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclatureJerold Chun, Edward J Goetzl, Timothy Hla, et al.
Pharmacological Reviews|May 31, 2002
Antioxidant therapy in acute central nervous system injury: current stateYossi Gilgun-Sherki, Ziv Rosenbaum, Eldad Melamed, et al.
Pharmacological Reviews|September 12, 2002
Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's diseaseYoo-Hun Suh, Frederic Checler
Pharmacological Reviews|May 18, 2001
The role of corticotropin-releasing factor in drug addictionZ Sarnyai, Y Shaham, S C Heinrichs
Pharmacological Reviews|May 18, 2001
Long-circulating and target-specific nanoparticles: theory to practiceS M Moghimi, A C Hunter, J C Murray
Pageof 83

Showing results (1-10 of 822) with videos related to

Sort By:
Pageof 83
Pharmacological Reviews|September 8, 2001
The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor familyJ S Mogil, G W Pasternak
Pharmacological Reviews|November 14, 2002
Pivalate-generating prodrugs and carnitine homeostasis in manEric P Brass
Pharmacological Reviews|November 14, 2002
Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart diseaseAngelika De Bree, W M Monique Verschuren, Daan Kromhout, et al.
Pharmacological Reviews|June 2, 2000
Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammationA W Griffioen, G Molema
Pharmacological Reviews|May 31, 2002
International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclatureAnthony P Davenport
Pharmacological Reviews|May 31, 2002
International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclatureJerold Chun, Edward J Goetzl, Timothy Hla, et al.
Pharmacological Reviews|May 31, 2002
Antioxidant therapy in acute central nervous system injury: current stateYossi Gilgun-Sherki, Ziv Rosenbaum, Eldad Melamed, et al.
Pharmacological Reviews|September 12, 2002
Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's diseaseYoo-Hun Suh, Frederic Checler
Pharmacological Reviews|May 18, 2001
The role of corticotropin-releasing factor in drug addictionZ Sarnyai, Y Shaham, S C Heinrichs
Pharmacological Reviews|May 18, 2001
Long-circulating and target-specific nanoparticles: theory to practiceS M Moghimi, A C Hunter, J C Murray
Pageof 83